Novel Corrector for Variants of SLC6A8: A Therapeutic Opportunity for Creatine Transporter Deficiency.

Autor: Gechijian LN; Jnana Therapeutics, Boston, Massachusetts 02210, United States., Muncipinto G; Third Harmonic Bio, Cambridge, Massachusetts 02139, United States., Rettenmaier TJ; Jnana Therapeutics, Boston, Massachusetts 02210, United States., Labenski MT; Jnana Therapeutics, Boston, Massachusetts 02210, United States., Rusu V; Apple Tree Partners, New York, New York 10169, United States., Rosskamp L; Jnana Therapeutics, Boston, Massachusetts 02210, United States., Conway L; Jnana Therapeutics, Boston, Massachusetts 02210, United States., van Kalken D; Jnana Therapeutics, Boston, Massachusetts 02210, United States., Gross L; Oregon State University, Portland, Oregon 97331, United States., Iantosca G; Atavistik Bio, Cambridge, Massachusetts 02140, United States., Crotty W; Neumora Tx, Watertown, Massachusetts 02472, United States., Mathis R; Jnana Therapeutics, Boston, Massachusetts 02210, United States., Park H; Jnana Therapeutics, Boston, Massachusetts 02210, United States., Rabin B; Brigham and Women's Hospital, Boston, Massachusetts 02115, United States., Westgate C; DG Medicines, Boston, Massachusetts 02115, United States., Lyons M; University of California, San Francisco, California 90095, United States., Deshusses C; University of North Carolina, Chapel Hill, North Carolina 27599, United States., Brandon N; Neumora Tx, Watertown, Massachusetts 02472, United States., Brown DG; Jnana Therapeutics, Boston, Massachusetts 02210, United States., Blanchette HS; Jnana Therapeutics, Boston, Massachusetts 02210, United States., Pullen N; ArtBio, Cambridge, Massachusetts 02139, United States., Jones LH; Center for Protein Degradation, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02215, United States., Barrish JC; RA Capital Ventures, Boston, Massachusetts 02116, United States.

Publikováno v: ACS chemical biology [ACS Chem Biol] 2024 Nov 15; Vol. 19 (11), pp. 2372-2382. Date of Electronic Publication: 2024 Oct 17.

Non-invasive study of 16th century Northern European chiaroscuro woodcuts: First insights

Autor: Laclavetine, K., Boust, C., Clivet, L., Le Hô, A.S., Laval, E., Mathis, R., Menu, M., Pagliano, E., Salmon, X., Selbach, V., Vrand, C., Lepape, S.

Publikováno v: In Microchemical Journal January 2019 144:419-430

Combining time-resolved multi-point and spatially-resolved measurements for the recovering of very-large-scale motions in high Reynolds number turbulent boundary layer

Autor: Kerhervé, F., Roux, S., Mathis, R.

Publikováno v: In Experimental Thermal and Fluid Science April 2017 82:102-115

Pathogenesis of Pressure Injuries.

Autor: Milner SM; Professor of Plastic and Reconstructive Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland (Ret.)., Mathis R; Department of Research and Development, PolarityTE, Inc, Salt Lake City, Utah.

Publikováno v: Eplasty [Eplasty] 2024 Mar 07; Vol. 24, pp. ic16. Date of Electronic Publication: 2024 Mar 07 (Print Publication: 2024).

Development and multi-center validation of a fully automated digital immunoassay for neurofilament light chain: toward a clinical blood test for neuronal injury.

Autor: Wilson D; Quanterix Corp, Billerica, MA, USA., Chan D; Quanterix Corp, Billerica, MA, USA., Chang L; Quanterix Corp, Billerica, MA, USA., Mathis R; Quanterix Corp, Billerica, MA, USA., Verberk I; Neurochemistry Laboratory, Department of Laboratory Medicine, Amsterdam Neuroscience, Amsterdam, University Medical Centers, Amsterdam, The Netherlands., Montalban X; Laboratori de Neuroinmunologia Clinica Centre d'Esclerosi Múltiple de Catalunya (Cemcat) Vall d'Hebron Institut de Recerca, Barcelona, Spain., Comabella M; Laboratori de Neuroinmunologia Clinica Centre d'Esclerosi Múltiple de Catalunya (Cemcat) Vall d'Hebron Institut de Recerca, Barcelona, Spain., Fissolo N; Laboratori de Neuroinmunologia Clinica Centre d'Esclerosi Múltiple de Catalunya (Cemcat) Vall d'Hebron Institut de Recerca, Barcelona, Spain., Bielekova B; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Masvekar R; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Chitnis T; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Ziemssen T; MS Center Dresden, Center of Clinical Neuroscience, Department of Neurology, Dresden University of Technology, Dresden, Germany., Akgün K; MS Center Dresden, Center of Clinical Neuroscience, Department of Neurology, Dresden University of Technology, Dresden, Germany., Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden., Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.; UK Dementia Research Institute at UCL, London, UK.; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China., Brück W; Institute for Neuropathology at the University Medical Center, Göttingen, Germany., Giovannoni G; Department of Neurology, Barts Health NHS Trust, The Royal London Hospital, E1 1FR, London, UK., Gnanapavan S; Department of Neurology, Barts Health NHS Trust, The Royal London Hospital, E1 1FR, London, UK., Bittner S; University Medical Center Mainz, Department of Neurology, Mainz, Germany., Zipp F; University Medical Center Mainz, Department of Neurology, Mainz, Germany., Comi G; Institute of Experimental Neurology, Division of Neuroscience, University Vita e Salute San Raffaele and IRCCS San Raffaele Hospital, Milan, Italy., Furlan R; Institute of Experimental Neurology, Division of Neuroscience, University Vita e Salute San Raffaele and IRCCS San Raffaele Hospital, Milan, Italy., Lehmann S; Hôpital St Eloi, Montpellier, France., Thebault S; University of Ottawa, Department of Medicine, The Ottawa Hospital Research Institute, Ottawa, Canada., Freedman M; University of Ottawa, Department of Medicine, The Ottawa Hospital Research Institute, Ottawa, Canada., Bar-Or A; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Kramer M; Sanofi, Framingham, MA, USA., Otto M; Department of Neurology, Ulm University Hospital, Ulm, Germany., Halbgebauer S; Department of Neurology, Ulm University Hospital, Ulm, Germany.; German Center for Neurodegenerative Diseases (DZNE e.V.), Ulm, Germany., Hrusovsky K; Quanterix Corp, Billerica, MA, USA., Plavina T; Quanterix Corp, Billerica, MA, USA., Khalil M; Department of Neurology, Medical University of Graz, Graz, Austria., Piehl F; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden., Wiendl H; Department of Neurology, University of Münster, Münster, Germany., Kappos L; Neurologic Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel, Departments of Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland., Maceski A; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Biomedicine and Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland., Willemse E; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Biomedicine and Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland., Leppert D; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Biomedicine and Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland., Teunissen C; Neurochemistry Laboratory, Department of Laboratory Medicine, Amsterdam Neuroscience, Amsterdam, University Medical Centers, Amsterdam, The Netherlands., Kuhle J; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Biomedicine and Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland.

Publikováno v: Clinical chemistry and laboratory medicine [Clin Chem Lab Med] 2023 Sep 13; Vol. 62 (2), pp. 322-331. Date of Electronic Publication: 2023 Sep 13 (Print Publication: 2024).